Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124162772 | 12416277 | 2 | F | 20160330 | 20160714 | 20160530 | 20160727 | EXP | JP-PFIZER INC-2016211432 | PFIZER | 77.00 | YR | M | Y | 53.00000 | KG | 20160727 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124162772 | 12416277 | 1 | PS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 4.5 G, 2X/DAY | 63 | G | Y | 50684 | 4.5 | G | BID | ||||
| 124162772 | 12416277 | 2 | SS | MEROPEN /01250501/ | MEROPENEM | 1 | Intravenous drip | 2 G, DAILY | Y | 0 | 2 | G | INJECTION | ||||||
| 124162772 | 12416277 | 3 | C | CRAVIT | LEVOFLOXACIN | 1 | Intravenous drip | 500 MG, DAILY | 0 | 500 | MG | INJECTION | |||||||
| 124162772 | 12416277 | 4 | C | REBAMIPIDE | REBAMIPIDE | 1 | Oral | 300 MG, DAILY | 0 | 300 | MG | ||||||||
| 124162772 | 12416277 | 5 | C | PERDIPINE | NICARDIPINE HYDROCHLORIDE | 1 | Oral | 30 MG, DAILY | 0 | 30 | MG | ||||||||
| 124162772 | 12416277 | 6 | C | HOKUNALIN /00654901/ | TULOBUTEROL | 1 | Ophthalmic | 2 MG, DAILY | 0 | 2 | MG | TRANSDERMAL PATCH | |||||||
| 124162772 | 12416277 | 7 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | ||||||||
| 124162772 | 12416277 | 8 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 124162772 | 12416277 | 9 | C | MUCODYNE | CARBOCYSTEINE | 1 | Oral | 750 MG, DAILY | 0 | 750 | MG | ||||||||
| 124162772 | 12416277 | 10 | C | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 8 MG, DAILY | 0 | 8 | MG | ||||||||
| 124162772 | 12416277 | 11 | C | INTAL | CROMOLYN SODIUM | 1 | Intraocular | UNK | 0 | ||||||||||
| 124162772 | 12416277 | 12 | C | NEOJODIN | 2 | UNK | 0 | ||||||||||||
| 124162772 | 12416277 | 13 | C | HIRUDOID | GLYCOSAMINOGLYCANS | 1 | Topical | UNK | 0 | ||||||||||
| 124162772 | 12416277 | 14 | C | RINDERON VG | BETAMETHASONE VALERATEGENTAMICIN SULFATE | 1 | Topical | UNK | 0 | ||||||||||
| 124162772 | 12416277 | 15 | C | NEOPHYLLIN /00003701/ | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124162772 | 12416277 | 1 | Pneumonia |
| 124162772 | 12416277 | 2 | Pneumonia |
| 124162772 | 12416277 | 3 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124162772 | 12416277 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124162772 | 12416277 | Drug eruption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124162772 | 12416277 | 1 | 20160323 | 20160329 | 0 | |
| 124162772 | 12416277 | 2 | 20160330 | 20160330 | 0 | |
| 124162772 | 12416277 | 3 | 20160331 | 0 |